KR100515928B1 - A composition for disinfecting and washing medical instruments comprising a surfactant having alcohol groups at the both terminals and a process for the preparation thereof 1 - Google Patents
A composition for disinfecting and washing medical instruments comprising a surfactant having alcohol groups at the both terminals and a process for the preparation thereof 1 Download PDFInfo
- Publication number
- KR100515928B1 KR100515928B1 KR10-2002-0051154A KR20020051154A KR100515928B1 KR 100515928 B1 KR100515928 B1 KR 100515928B1 KR 20020051154 A KR20020051154 A KR 20020051154A KR 100515928 B1 KR100515928 B1 KR 100515928B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- medical device
- surfactant
- acid
- disinfecting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/39—Organic or inorganic per-compounds
- C11D3/3947—Liquid compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/722—Ethers of polyoxyalkylene glycols having mixed oxyalkylene groups; Polyalkoxylated fatty alcohols or polyalkoxylated alkylaryl alcohols with mixed oxyalkylele groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/0005—Other compounding ingredients characterised by their effect
- C11D3/0073—Anticorrosion compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/02—Inorganic compounds ; Elemental compounds
- C11D3/04—Water-soluble compounds
- C11D3/042—Acids
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2075—Carboxylic acids-salts thereof
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/36—Organic compounds containing phosphorus
- C11D3/361—Phosphonates, phosphinates or phosphonites
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3703—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/3707—Polyethers, e.g. polyalkyleneoxides
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/39—Organic or inorganic per-compounds
- C11D3/3942—Inorganic per-compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/39—Organic or inorganic per-compounds
- C11D3/3945—Organic per-compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
Abstract
본 발명은 양쪽 말단에 알콜성 기를 갖는 계면활성제를 포함하는 과초산계 의료기기 소독 세척제에 관한 것으로서, 구체적으로는 과초산 0.08∼0.35 중량%, 초산 0.1∼20 중량%, 과산화수소 1∼6 중량%, 인산 0.1∼20 중량%, 1,1-디포스폰산 0.1∼5 중량%, 화학식 1의 구조를 갖는 적어도 1개의 계면활성제 0.001∼10 중량%, 및 부식방지제 0.001∼5 중량%를 포함하고, 나머지는 정제수, 역삼투압수, 또는 탈이온화 정제수로 이루어진 의료기기 소독 세척제 및 그의 제조방법에 관한 것이다.The present invention relates to a peracetic acid-based medical device disinfecting detergent comprising a surfactant having an alcoholic group at both ends, specifically, 0.08 to 0.35 wt% peracetic acid, 0.1 to 20 wt% acetic acid, 1 to 6 wt% hydrogen peroxide 0.1 to 20% by weight of phosphoric acid, 0.1 to 5% by weight of 1,1-diphosphonic acid, 0.001 to 10% by weight of at least one surfactant having a structure of Formula 1, and 0.001 to 5% by weight of a corrosion inhibitor, The remainder relates to a medical device disinfecting cleaning agent consisting of purified water, reverse osmosis water, or deionized purified water, and a method of manufacturing the same.
1 One
상기 식에서, l, m, 및 n은 각각 1∼50의 정수로서, l 및 n의 합은 2∼50이다.Wherein l, m and n are each an integer of 1 to 50, and the sum of l and n is 2 to 50.
Description
본 발명은 양쪽 말단에 알콜성 기를 갖는 계면활성제 및 부식방지제를 포함하는 과초산계 의료기기 소독 세척제 및 그의 제조방법에 관한 것이다. The present invention relates to a peracetic acid type medical device disinfecting detergent comprising a surfactant having an alcoholic group at both ends and a corrosion inhibitor, and a method of manufacturing the same.
1970년대 내시경이 시행된 이래로 현대 과학기술의 발전과 더불어 내시경 기기의 발전은 다양한 의료 영역으로 확대하고 있으며, 특히 소화기계 질환의 진단 및 치료에 있어서 획기적인 발전을 이룩하였다. 점차적으로 내시경 검사시행 건수가 증가하고 있는 추세이므로 안전하고도 효율적인 내시경 검사를 위해서는 내시경 의사의 능력과 기술, 내시경 기기의 기능 뿐만 아니라 내시경 검사로 인한 병원 감염에 대한 예방 대책이 중요하다고 할 수 있다. Since the endoscopy was implemented in the 1970s, with the development of modern science and technology, the development of endoscopy equipment has been expanded to various medical fields. As the number of endoscopic examinations is gradually increasing, it is important for the safe and efficient endoscopy to be preventive measures against hospital infections due to endoscopy as well as the ability and skills of endoscopy, the function of endoscopy equipment.
1960년대에 개발된 글루터알데히드계 소독제는 유효성면에서 높은 인지도를 가져 지금까지도 사용되고 있으나 사용자에 대한 안전성과 환경문제가 보고 되면서 그 사용영역이 점차 제한되고 있는 실정이다. 더욱이 근래에는 여러 가지 이유로 인하여 내시경 검사에 의한 병원 감염의 가능성이 점차로 높아지고 있으며 또한 우리나라와 같이 한 대의 내시경으로 연속해서 여러 사람을 검사하는 병·의원이 많은 현실에 있어서 내시경에 의한 감염에 대한 대책이 아주 시급하다 할 수 있다. 1980년을 전후하여 미국, 영국 및 일본에서는 내시경 검사에 의한 병원 감염의 심각성을 인식하기 시작하여 내시경 기기 소독에 대한 제도적인 뒷받침, 전담 인력의 배치, 내시경 기기 소독방법에 대한 지침의 연구와 효과적인 방법의 모색이 지속되고 있다. 내시경에 의한 감염의 대상에는 환자뿐만 아니라 내시경의를 비롯한 내시경실 종사자의 감염도 이 범주에 포함되므로 병원 감염(예를들어, 헬리코박터파이로리, 결핵균등)에 대한 새로운 인식이 필요한 시점이라 할 수 있다. The glutaraldehyde-based disinfectants developed in the 1960s have a high level of recognition in terms of effectiveness and are still used. However, as the safety and environmental problems for users are reported, their use is increasingly limited. In recent years, the possibility of hospital infection by endoscopy is increasing for a variety of reasons, and in reality, there are many hospitals and clinics that examine several people in a row with one endoscope in Korea. It is very urgent. Around 1980, the United States, the United Kingdom, and Japan began to recognize the severity of hospital infections by endoscopy, providing institutional support for endoscopy disinfection, the assignment of dedicated personnel, and guidelines for how to disinfect endoscopy instruments. The search for continued. Endoscopic infections include infections not only of patients but also of endoscopy workers, including endoscopists, and thus require new awareness of hospital infections (eg, Helicobacter pylori, tuberculosis, etc.).
또한, 상기와 같은 내시경 기기 이외에도, 외과 수술용 기구, 일반 의료기구, 마취기, 인공호흡기 또는 이들의 주변장치, 산부인과용 기구, 치과용 기구 또는 한방 의료 기구 등에 있어서도 충분한 세척을 통한 병원 감염방지는 필수적이라 할 수 있다.In addition to the endoscope device as described above, it is also essential to prevent hospital infection through sufficient cleaning in surgical instruments, general medical instruments, anesthesia, respirators or their peripheral devices, gynecological instruments, dental instruments, or herbal medical instruments. This can be called.
종래에 상기 의료기기 세척을 위해 사용되어온 통상의 소독제(예를들어, 글루타르 알데히드 등)는 속효성에 문제가 있고, 소독의 효능(종전 멸균수준은 10시간 이상) 및 시간적인 문제 (종전 살균수준은 30분 이상) 등의 문제가 있다.Conventional disinfectants (eg, glutaraldehyde, etc.), which have been used for cleaning the medical device in the past, have problems with fastness, efficacy of disinfection (previous sterilization level of 10 hours or more) and time problems (previous sterilization level). Is 30 minutes or more).
한편, 과초산, 초산, 및 과산화수소를 함유하는 과초산계 의료기기 소독 세척제가 개발된 바 있다 (국제특허공개 제WO 88/08667호, 국제특허공개 제WO 93/07909호, 국제특허공개 제WO 94/14321호, 유럽특허공개 제EP 193,426호, 유럽특허공개 제EP 596493호, 미국특허 제US 6168,808호, 한국특허공개 제2000-49667호 등).Meanwhile, peracetic acid-based medical device disinfectant cleaners containing peracetic acid, acetic acid, and hydrogen peroxide have been developed (WO 88/08667, WO 93/07909, WO WO). 94/14321, European Patent Publication No. EP 193,426, European Patent Publication No. EP 596493, US Patent No. US 6168,808, Korean Patent Publication No. 2000-49667, and the like.
상기한 종래의 과초산계 의료기기 소독 세척제들은 과초산, 초산, 과산화수소, 및 정제수를 함유하며, 인산, 포스폰산 등의 안정화제, 소르비탄 모노팔미테이트, 폴리옥시에틸렌 세틸 에테르 등의 비이온성 계면활성제, 또는 아민옥사이드류(amine oxides) 등을 포함하고 있다.The conventional peracetic acid-based medical device disinfectant cleaners contain peracetic acid, acetic acid, hydrogen peroxide, and purified water, and nonionic interfaces such as stabilizers such as phosphoric acid and phosphonic acid, sorbitan monopalmitate, and polyoxyethylene cetyl ether. Active agents, or amine oxides.
그러나, 상기 과초산계 소독 세척제는 빠른 살균력으로 자동세척기 및 손세척에 적합한 제품이라 할 수 있으나, 과초산의 함량이 낮은(예를들어, 1 중량% 미만) 소독 세척제의 경우 환자의 점액등에 대한 유기물의 오염에 대하여 세척력이 낮아 그 사용이 제한적일 수 밖에 없다. 또한, 과초산 함량이 낮은 소독 세척제는 주로 내시경 기기, 포셉 및 외과 수술용 기구 등에 사용하게 되는데, 이들 기구들 중 구리 및 아연화합물 등을 함유한 것도 있어 과초산계 소독 세척제에 의한 부식문제가 발생한다.However, the peracetic acid disinfectant cleaner may be referred to as a product suitable for automatic washing and hand washing with fast disinfection, but in the case of a disinfectant detergent having a low peracetic acid content (for example, less than 1 wt%), Low cleaning power against contamination of organic matter is limited to its use. In addition, disinfectant cleaners with low peracetic acid content are mainly used for endoscopy instruments, forceps, and surgical instruments. Some of these instruments contain copper and zinc compounds, causing corrosion problems caused by peracetic acid disinfectant cleaners. do.
또한, 종래의 과초산계 의료기기 소독 세척제중 계면활성제가 첨가된 소독 세척제를 사용하는 경우, 기포 발생을 충분히 억제하지 못하기 때문에 기포가 발생하게 되며, 기포가 발생한 경우 소독 세척제와 의료기기와의 접촉을 방해함으로써 충분한 소독 및 세척이 이루어지지 않는 문제점이 있다. In addition, in the case of using a disinfectant detergent added with a surfactant in the conventional peracetic acid-based medical disinfectant detergent, bubbles are generated because bubbles are not sufficiently suppressed, and when bubbles are generated, contact between the disinfectant detergent and the medical device is generated. There is a problem that the sufficient disinfection and cleaning is not made by preventing the.
이에, 본 발명자들은 낮은 함량의 과초산 함유 의료기기 소독 세척제에 있어서의 문제점을 해결하고자 연구를 거듭한 결과, 과초산계 소독 세척제에 양쪽 말단에 알콜성 기를 갖는 계면활성제 및 일정한 부식방지제를 첨가하여 사용할 경우, 세척력을 증진시킬 뿐 아니라, 기포 발생으로 인한 문제점 및 부식의 문제점을 최소화할 수 있다는 것을 발견하여 본 발명을 완성하기에 이르렀다. Accordingly, the present inventors have conducted a study to solve the problem in the low content peracetic acid-containing medical device disinfectant detergents, by adding a surfactant having a alcoholic group at both ends and a constant corrosion inhibitor to the peracetic acid disinfectant detergent When used, the present invention has been found to be able to minimize cleaning problems and corrosion problems, as well as to improve cleaning power.
따라서, 본 발명은 높은 세척력 및 살균력을 나타내면서, 기포발생 및 부식의 문제점이 최소화된, 특정 계면활성제를 포함하는 의료기기 소독 세척제를 제공하는 것을 목적으로 한다.Accordingly, an object of the present invention is to provide a medical device disinfecting cleaning agent containing a specific surfactant, while exhibiting high cleaning and sterilizing power, and minimizing the problems of bubble generation and corrosion.
또한, 본 발명의 목적은 상기 의료기기 소독 세척제를 제조하는 방법을 제공하는 것을 포함한다. It is also an object of the present invention to provide a method for producing the medical device disinfectant cleaner.
본 발명의 의료기기 소독 세척제는 과초산 0.08∼0.35 중량%, 초산 0.1∼20 중량%, 과산화수소 1∼6 중량%, 인산 0.1∼20 중량%, 1,1-디포스폰산 0.1∼5 중량%, 화학식 1의 구조를 갖는 적어도 1개의 계면활성제 0.001∼10 중량%, 및 부식방지제 0.001∼5 중량%를 포함하고, 나머지는 정제수, 역삼투압수, 또는 탈이온화 정제수로 이루어진 의료기기 소독 세척제이다. Medical device disinfectant cleaning agent of the present invention is 0.08 to 0.35% by weight peracetic acid, 0.1 to 20% by weight acetic acid, 1 to 6% by weight hydrogen peroxide, 0.1 to 20% by weight phosphoric acid, 0.1 to 5% by weight 1,1-diphosphonic acid, 0.001 to 10% by weight of at least one surfactant having a structure of Formula 1, and 0.001 to 5% by weight of a corrosion inhibitor, and the rest is a medical device disinfecting cleanser consisting of purified water, reverse osmosis water, or deionized purified water.
상기 식에서, l, m, 및 n은 각각 1∼50의 정수로서, l 및 n의 합은 2∼50이다.Wherein l, m and n are each an integer of 1 to 50, and the sum of l and n is 2 to 50.
상기 과초산 및 과산화 수소는 본 발명의 소독 세척제가 가지는 기능인 살균 기능에 직접적으로 관여하는 성분으로서, 이들 각 성분은 본 발명의 소독 세척제에서 평형상태로 존재하게 된다.The peracetic acid and hydrogen peroxide are components directly involved in the sterilization function which is a function of the disinfectant cleaner of the present invention, and each of these components will exist in an equilibrium state in the disinfectant cleaner of the present invention.
상기 인산(phosphoric acid) 및 1,1-디포스폰산(1,1-diphosphonic acid)은 혼합 안정화제로서, 각각의 구조는 다음과 같다.The phosphoric acid (phosphoric acid) and 1,1-diphosphonic acid (1,1-diphosphonic acid) is a mixed stabilizer, each structure is as follows.
이러한, 인산 및 1,1-디포스폰산은 본 발명의 소독 세척제에서 상기한 과초산 및 과산화수소를 안정화시키는 역할 외에 탄산칼슘, 칼슘 설페이트 등의 스케일 제거력을 향상시키는 효과를 가지고 있다. 또한, 본 발명의 소독 세척제는 안정화제로서 인산을 혼합사용함으로써 탄산칼슘, 탄산칼륨 등의 스케일을 효과적으로 제거하기 위한 산성의 산도를 부여한다. 따라서, 본 발명에서 사용한 혼합안정화제는 안정화제로서의 효과 뿐 아니라 소독 세척제의 산도를 바람직한 범위로 제조할 수 있도록 한다. Such, phosphoric acid and 1,1-diphosphonic acid has the effect of improving the scale removal ability of calcium carbonate, calcium sulfate, etc. in addition to stabilizing the peracetic acid and hydrogen peroxide in the disinfecting cleaning agent of the present invention. In addition, the disinfectant cleaning agent of the present invention gives an acidity for removing the scale of calcium carbonate, potassium carbonate and the like effectively by mixing phosphoric acid as a stabilizer. Therefore, the mixed stabilizer used in the present invention enables to prepare not only the effect as a stabilizer but also the acidity of the disinfectant cleaning agent in a preferable range.
또한, 본 발명에서 특징적으로 사용하는 계면활성제는 다음 화학식 1의 구조를 가지는 것이면 어느 것이나 이용될 수 있다.In addition, any surfactant that is characteristically used in the present invention may be used as long as it has the structure of Formula 1.
1 One
(상기 식에서, l, m, 및 n은 각각 1∼50의 정수로서, l 및 n의 합은 2∼50이다.)(Wherein l, m, and n are each an integer of 1 to 50, and the sum of l and n is 2 to 50).
상기 계면활성제는 바람직하기로는, l+n 즉, 에틸렌옥사이드 부위의 함량이 약 4∼50 몰이고, m 즉, 프로필렌 옥사이드 부위의 함량이 약 5∼40 몰인 것이다. 또한, 상기 계면활성제의 분자량은 1500∼3000 이 바람직하며, 약 2,500인 것이 더욱 바람직하다. 또한, 본 발명에 사용가능한 계면활성제로는 상기 요건을 갖는 상업적으로 판매되는 계면활성제, 예를 들면, 상품명 Koremul-PE62(한농화성) 등의 폴리옥시에틸렌 및 옥시프로필렌 블록 공중합체를 사용할 수도 있다. Preferably, the surfactant is l + n, that is, the content of the ethylene oxide moiety is about 4 to 50 moles, and m, that is, the content of the propylene oxide moiety is about 5 to 40 moles. In addition, the molecular weight of the surfactant is preferably 1500 to 3000, more preferably about 2,500. In addition, as the surfactant usable in the present invention, commercially available surfactants having the above requirements, for example, polyoxyethylene and oxypropylene block copolymers such as the brand name Koremul-PE62 (ultra-concentrated) may be used.
본 발명의 소독 세척제에서 특징적으로 사용하는 상기 계면활성제는 과산화물에 대하여 안정성과 저기포성, 세척력 및 낮은 독성을 가진다. 따라서, 낮은 함량의 과초산을 함유하고도 의료기기 소독 세척제의 세척력을 향상시킬 수 있다. 또한, 상기 계면활성제는 의료기기 세척시 낮은 표면장력과 발생되는 기포가 적으므로, 소포제를 사용함으로써 발생하는 종래의 의료기기 세척제의 환경 등에 대한 문제점을 효과적으로 해결할 수 있다. The surfactants characteristically used in the disinfectant cleaner of the present invention have stability, low foaming ability, detergency and low toxicity to peroxides. Therefore, even if it contains a low content of peracetic acid can improve the cleaning power of the medical device disinfectant cleaner. In addition, since the surfactant has low surface tension and fewer bubbles generated during cleaning of the medical device, problems with the environment of the conventional medical device cleaning agent generated by using the antifoaming agent can be effectively solved.
본 발명의 의료기기 소독 세척제에 사용가능한 부식방지제로는 소듐 실리케이트, 소듐 나이트레이트, 소듐 벤조에이트, 벤조트리아졸, 폴리아크릴레이트 공중합물로 이루어진 군으로부터 하나 이상 선택된 것을 사용하는 것이 알루미늄, 구리, 및/또는 아연 화합물 등에 대하여 부식방지성을 가지므로 바람직하다. 여기에서 폴리아크릴레이트 공중합물로는 분자량 50,000∼100,000을 가지는 공중합물로서 pH 2∼3의 공중합물이 바람직하며, 상업적으로 판매되는 아크리졸(Acrysol, Rohm&Hass사), 소칼란(Sokalan, BASF사), 티피에이50(TPA50, 태창물산) 등을 사용할 수도 있다.Corrosion inhibitors that can be used in the medical device disinfecting cleaning agents of the present invention include aluminum silica, copper, and one or more selected from the group consisting of sodium silicate, sodium nitrate, sodium benzoate, benzotriazole, and polyacrylate copolymers. It is preferable because it has corrosion protection against zinc compounds and the like. Here, as the polyacrylate copolymer, a copolymer having a molecular weight of 50,000 to 100,000 is preferably a copolymer of pH 2-3, and commercially available acrysol (Acrysol, Rohm & Hass), Sokalan (Sokalan, BASF), TPA 50 (TPA50, Taechang Products) etc. can also be used.
본 발명의 의료기기 소독 세척제는 용매로서 물을 사용할 수 있으며, 순수에 가깝고 오염되지 않은 정제수가 바람직하며, 역삼투압수 또는 탈이온화 증류수 등이 더욱 바람직하다. The medical device disinfectant cleaning agent of the present invention may use water as a solvent, preferably purified water that is close to pure water and uncontaminated, and more preferably reverse osmosis water or deionized distilled water.
본 발명의 의료기기 소독 세척제중에 함유되는 모든 성분들의 함량은 평형상태를 이루고 있는 최종 소독 세척제중의 함량을 나타내는 것이다. The content of all components contained in the medical device disinfecting detergent of the present invention indicates the content of the final disinfecting detergent in equilibrium.
즉, 평형상태를 이루고 있는 소독 세척제중 과초산은 0.08∼0.35 중량%, 초산은 0.1∼20 중량%, 및 과산화수소는 1∼6 중량%의 함량이 바람직하다. 물론, 이들 함량은 충분한 세척력 및 살균력을 목적으로 상기 범위를 약간씩 벗어날 수 있으나, 이는 본 발명의 의료기기 소독 세척액의 범위에 포함되는 것으로 해석되어야 한다. That is, the content of the peracetic acid is 0.08 to 0.35% by weight, the acetic acid is 0.1 to 20% by weight, and the hydrogen peroxide is preferably 1 to 6% by weight in the disinfecting detergent in equilibrium. Of course, these contents may deviate slightly from the above range for the purpose of sufficient cleaning power and sterilization power, but it should be interpreted as being included in the scope of the medical device disinfecting cleaning liquid of the present invention.
또한, 안정화제 및 스케일 제거제로서 함유되는 인산 및 1,1-디포스폰산은 각각 0.1∼20 중량% 및 0.1∼5 중량%으로 함유되는 것이 바람직하다. 물론, 이들 함량도 충분한 안정화 및 스케일 제거효과를 목적으로 상기 범위를 약간씩 벗어날 수 있으나, 이는 본 발명의 의료기기 소독 세척제의 범위에 포함되는 것으로 해석되어야 한다. In addition, it is preferable that phosphoric acid and 1,1-diphosphonic acid contained as a stabilizer and a descaling agent are contained in 0.1-20 weight% and 0.1-5 weight%, respectively. Of course, these contents may also slightly out of the above range for the purpose of sufficient stabilization and descaling effect, it should be construed to fall within the scope of the medical device disinfecting cleaning agent of the present invention.
본 발명에서 특징적으로 함유되는 화학식 1의 구조를 갖는 계면활성제의 함량으로는 0.001∼10 중량%가 바람직하며, 0.5∼5 중량%가 더욱 바람직하다. As content of surfactant which has the structure of Formula (1) characteristically contained in this invention, 0.001-10 weight% is preferable, and 0.5-5 weight% is more preferable.
본 발명의 의료기기 소독 세척제에 함유되는 부식방지제는 0.001∼5 중량%의 함량이 바람직하다. 물론, 해당 함량은 충분한 부식방지를 목적으로 상기 범위를 약간씩 벗어날 수 있으나, 이는 본 발명의 의료기기 소독 세척제의 범위에 포함되는 것으로 해석되어야 한다.The corrosion inhibitor contained in the medical device disinfecting cleaning agent of the present invention is preferably 0.001 to 5% by weight. Of course, the content may be slightly out of the above range for the purpose of sufficient corrosion protection, it should be construed to fall within the scope of the medical device disinfecting cleaning agent of the present invention.
본 발명의 소독 세척제에 용매 또는 희석제로 사용되는 정제수, 역삼투압수, 또는 탈이온화 정제수 등의 함량은 최종 조성물에서 상기 성분의 함량을 충족시키고 남은 양을 100%로 맞추기에 적당한 양으로 사용한다. The content of purified water, reverse osmosis water, or deionized purified water used as a solvent or diluent in the disinfectant cleaner of the present invention is used in an amount suitable to satisfy the content of the above components in the final composition and to adjust the remaining amount to 100%.
본 발명의 의료기기 소독 세척제를 사용하여 세척할 수 있는 의료기기에는 특별한 제한은 없으나, 내시경 기기, 외과 수술용 기구, 일반 의료기구, 마취기, 인공호흡기 또는 이들의 주변장치, 산부인과용 기구, 치과용 기구 또는 한방 의료 기구에 사용하는 것이 바람직하다.Medical devices that can be cleaned using the medical device disinfectant cleaning agent of the present invention is not particularly limited, but endoscope equipment, surgical instruments, general medical equipment, anesthesia, respirator or peripherals thereof, obstetrics, dental, dental It is preferable to use the apparatus or the herbal medical apparatus.
본 발명은 상기 의료기기 소독 세척제의 제조방법을 포함한다.The present invention includes a method for producing the medical device disinfectant cleaner.
즉, 본 발명은 정제수, 더욱 바람직하게는 역삼투압수 또는 탈이온화 정제수, 79∼80 중량%와 인산 및 1,1-디포스폰산을 각각 0.1∼1.0 중량%, 0.1∼10 중량% 혼합하는 단계;That is, the present invention is a step of mixing purified water, more preferably reverse osmosis water or deionized purified water, 79 to 80% by weight and phosphoric acid and 1,1-diphosphonic acid, respectively 0.1 to 1.0% by weight, 0.1 to 10% by weight ;
초산 0.2∼2.0 중량%를 혼합하는 단계;Mixing 0.2 to 2.0 wt% acetic acid;
과산화수소 5∼7 중량%를 혼합하여 과초산을 형성하는 단계;Mixing 5-7 wt% hydrogen peroxide to form peracetic acid;
상기 혼합물을 35∼45℃에서 4∼7시간동안 보온한 다음, 상온에서 숙성시키는 단계;Incubating the mixture at 35 to 45 ° C. for 4 to 7 hours and then aging at room temperature;
소듐 실리케이트, 소듐 나이트레이트, 소듐 벤조에이트, 벤조트리아졸, 폴리아크릴레이트 공중합물로 이루어진 군으로부터 하나 이상 선택된 부식방지제 0.001∼5 중량%를 혼합하는 단계; 및Mixing 0.001 to 5% by weight of one or more preservatives selected from the group consisting of sodium silicate, sodium nitrate, sodium benzoate, benzotriazole, polyacrylate copolymer; And
화학식 1의 구조를 갖는 적어도 1개의 계면활성제 0.001∼10 중량%를 혼합하는 단계를 포함하는 의료기기 소독 세척제의 제조방법을 포함한다.It includes a method for producing a medical device disinfecting cleaning agent comprising the step of mixing at least 0.001 to 10% by weight of at least one surfactant having a structure of formula (1).
상기 제조방법에서 보온단계는 과산화수소 및 초산의 반응을 촉진하기 위한 것이며, 숙성단계는 과산화수소의 함량을 적절한 수준으로, 예를들어 6 중량% 이하로 조정하는 단계로서 약 3일간 숙성시키는 것이 바람직하다.In the preparation method, the warming step is for promoting the reaction of hydrogen peroxide and acetic acid, and the aging step is preferably a step of adjusting the content of hydrogen peroxide to an appropriate level, for example, 6 wt% or less, for about three days.
상기 의료기기 소독 세척제는 접촉시간을 5∼10분 정도로 사용함으로써, 내시경 기기, 외과 수술용 기구, 일반 의료기구, 마취기, 인공호흡기 또는 이들의 주변장치, 산부인과용 기구, 치과용 기구 또는 한방 의료 기구 등의 의료기기를 효과적으로 세척할 수 있다. 물론, 상기 접촉시간은 필요에 따라 감소 또는 증가시킬 수 있다. 본 발명에 따른 저농도 과초산 함유 소독 세척제는 별도로 희석할 필요가 없으나, 필요할 경우 당업계에서 허용하는 범위내에서 적절히 희석하여 사용할 수도 있다. 희석제로는 수성 용매, 바람직하기로는 정제수, 역삼투압수, 탈이온화 정제수 등이 바람직하다.The medical device disinfectant cleaning agent uses a contact time of about 5 to 10 minutes, so that the endoscopic device, surgical instrument, general medical device, anesthesia machine, respirator or its peripheral device, gynecological device, dental device or oriental medical device It is possible to effectively clean such medical devices. Of course, the contact time can be reduced or increased as needed. The low concentration peracetic acid-containing disinfecting detergent according to the present invention does not need to be diluted separately, but may be used if appropriately diluted within the allowable range in the art if necessary. As a diluent, an aqueous solvent, Preferably purified water, reverse osmosis water, deionized purified water, etc. are preferable.
이하 본 발명을 실시예를 통하여 보다 구체적으로 설명한다. 그러나, 이들 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다. Hereinafter, the present invention will be described in more detail with reference to Examples. However, these Examples are intended to illustrate the present invention more specifically, but the scope of the present invention is not limited to these Examples.
실시예 1: 본 발명의 의료기기 소독 세척제의 제조예Example 1 Preparation Example of Medical Device Disinfecting Cleanser of the Present Invention
역삼투압수 88.3g과 인산 및 1,1-디포스폰산을 각각 1.0g, 0.1g을 혼합한 다음, 초산 1g을 혼합하였다. 여기에 과산화수소 6g을 혼합하여 과초산을 형성시키고, 35∼45℃에서 7시간동안 보온하였다. 이를 상온에서 교반하여 숙성시킨 다음, 티피에이50(TPA50, 태창물산) 0.5g을 가한 후, 순차적으로 소듐 벤조에이트 0.2g, 벤조트리아졸 0.2g, 소듐 나이트레이트 0.5g, 소듐 실리케이트 0.1g를 가한 후, Koremul - PE62 (한농화성)의 폴리 옥시에틸렌 및 옥시프로필렌 블록 공중합체 2g을 가하여 의료기기 소독 세척제를 제조하였다. 얻어진 소독 세척제중 과초산 및 과산화수소의 농도는 각각 0.35% 및 2.02% 였다.Reverse osmosis water 88.3 g, phosphoric acid and 1,1-diphosphonic acid were mixed 1.0 g and 0.1 g, respectively, followed by 1 g of acetic acid. 6 g of hydrogen peroxide was mixed thereto to form peracetic acid, and kept at 35 to 45 ° C. for 7 hours. After aging by stirring at room temperature, 0.5 g of TPA 50 (TPA50, Taechang Products) was added, followed by 0.2 g of sodium benzoate, 0.2 g of benzotriazole, 0.5 g of sodium nitrate, and 0.1 g of sodium silicate. Thereafter, 2 g of polyoxyethylene and oxypropylene block copolymers of Koremul-PE62 (hyperconcentrate) were added to prepare a disinfectant cleaner for medical devices. The concentrations of peracetic acid and hydrogen peroxide in the obtained disinfecting detergents were 0.35% and 2.02%, respectively.
실시예 2: 본 발명의 의료기기 소독 세척제의 제조예Example 2: Preparation of Medical Device Disinfecting Cleanser of the Present Invention
초산 0.3g을 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 의료기기 소독 세척제를 제조하였으며, 얻어진 소독 세척제중 과초산 및 과산화수소의 농도는 각각 0.20% 및 2.10% 였다.Except that 0.3g of acetic acid was used, a medical device disinfecting detergent was prepared in the same manner as in Example 1, and the concentrations of peracetic acid and hydrogen peroxide in the obtained disinfecting detergent were 0.20% and 2.10%, respectively.
실시예 3: 본 발명의 의료기기 소독 세척제의 제조예Example 3: Preparation of Medical Device Disinfecting Cleanser of the Present Invention
초산 0.1g을 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 의료기기 소독 세척제를 제조하였으며, 얻어진 소독 세척제중 과초산 및 과산화수소의 농도는 각각 0.09% 및 2.20% 였다.Except that 0.1g of acetic acid was used, the medical device disinfecting detergent was prepared in the same manner as in Example 1, and the concentrations of peracetic acid and hydrogen peroxide were 0.09% and 2.20%, respectively.
실시예 4: 본 발명의 의료기기 소독 세척제의 제조예Example 4 Preparation of Medical Device Disinfecting Cleanser of the Present Invention
초산 0.3g 및 과산화수소 3.0g을 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 의료기기 소독 세척제를 제조하였으며, 얻어진 소독 세척제중 과초산 및 과산화수소의 농도는 각각 0.18% 및 1.01% 였다. A medical device disinfectant cleaner was prepared in the same manner as in Example 1 except that 0.3 g of acetic acid and 3.0 g of hydrogen peroxide were used, and the concentrations of peracetic acid and hydrogen peroxide in the disinfectant cleaners obtained were 0.18% and 1.01%, respectively.
실시예 5: 본 발명의 의료기기 소독 세척제의 제조예Example 5 Preparation of Medical Device Disinfecting Cleanser of the Present Invention
초산 0.1g 및 과산화수소 3.0g을 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 의료기기 소독 세척제를 제조하였으며, 얻어진 소독 세척제중 과초산 및 과산화수소의 농도는 각각 0.08% 및 1.05% 였다. Medical device disinfectant cleaners were prepared in the same manner as in Example 1, except that 0.1 g of acetic acid and 3.0 g of hydrogen peroxide were used, and the concentrations of peracetic acid and hydrogen peroxide were 0.08% and 1.05%, respectively.
실시예6 : 부식성 시험(1)Example 6 Corrosion Test (1)
알루미늄 시험편의 표면을 70%질산을 사용하여 부식생성물 및 불순물을 제거한 후, 실시예 1에서 제조한 소독 세척제로 5시간 동안 접촉시킨 다음, 부식편의 무게를 측정한 후, 하기 식에 의하여 부식속도를 구하였다.After removing the corrosion products and impurities using the 70% nitric acid on the surface of the aluminum test piece, contact with the disinfectant detergent prepared in Example 1 for 5 hours, and after weighing the weight of the corrosion piece, the corrosion rate by the following formula Obtained.
부식속도 = 534X(무게손실) / {(밀도g/cm3)X(부식편의 면적in2)X(시간hour)}Corrosion Rate = 534X (Weight Loss) / {(Density g / cm 3 ) X (Area of Corrosion Pieces in 2 ) X (hour)}
상기 식에 따라 측정한 부식속도는 1.67 mm/yr였다. 따라서, 통상의 과초산계 소독 세척제의 부식속도 2.68 mm/yr와 비교시 본 발명의 소독 세척제는 부식의 문제가 유의성있게 감소하였음을 알 수 있다.The corrosion rate measured according to the above formula was 1.67 mm / yr. Accordingly, it can be seen that the disinfectant cleaner of the present invention significantly reduced the problem of corrosion as compared with the corrosion rate of 2.68 mm / yr of the conventional peracetic acid disinfectant cleaner.
실시예7 : 부식성 시험(2)Example 7 Corrosion Test (2)
황동 시험편의 표면을 20%염산을 사용하여 부식생성물 및 불순물을 제거한 후, 실시예 1에서 제조한 소독 세척제로 30분 동안 접촉시킨 다음, 부식편의 무게를 측정한 다음, 실시예 6과 동일한 방법으로 부식속도를 구한 결과, 부식속도는 5.25 mm/yr였다. 따라서, 통상의 과초산계 소독 세척제의 부식속도 109.37 mm/yr와 비교시 본 발명의 소독 세척제는 부식의 문제가 유의성있게 감소하였음을 알 수 있다.The surface of the brass test piece was removed using 20% hydrochloric acid to remove the corrosion product and impurities, and then contacted with the disinfectant cleaner prepared in Example 1 for 30 minutes, and then the weight of the corrosion piece was measured. The corrosion rate was found to be 5.25 mm / yr. Accordingly, it can be seen that the disinfectant cleaner of the present invention significantly reduced the problem of corrosion as compared to the corrosion rate of 109.37 mm / yr of the conventional peracetic acid disinfectant cleaner.
실시예8 : 세척/소독력 시험Example 8 Wash / Disinfection Test
현재 상업적으로 사용중인 내시경기기(제조사: 올림푸스 및 모델번호: GIF-P20)를 약 1개월간 사용하면서, 실시예 1에서 제조한 소독 세척제로 세척하여 살균력을 시험하였다.While using a commercially available endoscope (manufacturer: Olympus and Model No .: GIF-P20) for about one month, the sterilization power was tested by washing with the disinfecting detergent prepared in Example 1.
소화기 내시경학회에서 이용하는 지침을 기본으로 하여 소독 및 세척하였으며, 내시경으로부터 검체의 채취 및 배양은 소독을 마친 내시경을 한대의 내시경당 2부위에서 검체를 채취하였다.Sterilization and cleaning were performed based on the guidelines used by the Gastrointestinal Endoscopy Society. Samples and cultures were taken from two sites per endoscope for the disinfection of the endoscope.
50ml주사기를 이용하여 30ml의 생리식염수를 생검 구멍을 통하여 흡입채널로 천천히 주입하면서 삽입부의 말단으로 떨어지는 물을 멸균된 튜브에 모았다(S-1검체). 또한, 내시경 삽입부의 말단과 몸체연결부위 사이를 생리식염수로 적신 면봉으로 도말하였다(S-2검체). 내시경 자동세척기 자체의 세균오염을 확인하기 위하여 필터를 통과한 행굼액 100ml를 2회 채취하였다. While slowly injecting 30 ml of physiological saline into the suction channel through the biopsy hole using a 50 ml syringe, water falling to the end of the insert was collected in a sterile tube (S-1 sample). In addition, between the end of the endoscope insertion portion and the body connecting portion was smeared with a cotton swab soaked with saline (S-2 sample). In order to confirm the bacterial contamination of the endoscope auto washer itself, 100 ml of the rinse solution passed through the filter was collected twice.
S-1검채와 내시경 자동 세척기의 헹굼액에서 얻은 검체는 음압하에서 0.22μm 셀룰로오즈 니트레이트 여과막(cellulose nitrate membrane filter)에 통과를 시키고 즉시 여과막(membrane filter)을 들어내어 혈액한천배지에 골고루 펼쳤다. 면봉으로 채취한 S-2검체는 혈액한천배지에 직접 골고루 접종하였다. 살균력 시험결과는 다음 표1와 같다.Samples obtained from the rinse solution of the S-1 probe and the endoscope auto washer were passed through a 0.22 μm cellulose nitrate membrane filter under negative pressure and immediately lifted a membrane filter and spread evenly on the blood agar medium. S-2 samples from cotton swabs were evenly inoculated directly into blood agar medium. The test results of bactericidal power are shown in Table 1 below.
상기 표1에서 확인할 수 있는 바와 같이, 본 발명의 소독 세척제는 효과적으로 내시경 기기를 소독 세척할 수 있음을 알 수 있으며, 내시경 기기를 기포발생없이 효과적으로 세척할 수 있었으며, 부식의 문제도 전혀 발생하지 않았다. As can be seen in Table 1, it can be seen that the disinfectant cleaning agent of the present invention can effectively disinfect and clean the endoscope device, it was possible to effectively clean the endoscope device without foaming, and no problems of corrosion occurred. .
실시예9 : 살균력 시험Example 9: Sterilization Test
세균 및 진균에 대한 살균력을 다음과 같이 시험하였다.The bactericidal activity against bacteria and fungi was tested as follows.
1. 세균 살균력 시험1. Bacterial bactericidal test
영양배지(Nutrient broth) 및 트립신 함유 배지(Tryptic soy broth)에서 24시간 배양한 균액 0.1 ml과 실시예 1에서 제조한 소독 세척제 10 ml을 진탕혼합하여 1분 동안 반응시켰다. 1분 후, 반응액 1 ml을 즉시 9 ml의 중화제(4.26% 소디움포스페이트 디베이직, 3% 트윈(Tween), 0.5% 소디움티오설페이트 펜타하이드레이트, 0.3% L-α-레시틴, 및 0.1% L-히스티딘)가 든 시험관에 취하였다. 혼합액 1 ml을 취하여 펩톤수로 10배 희석하였다. 혼합액의 원액과 10배 희석한 희석액 각각을 미리 제조하여 굳혀 둔 평판배지에 0.1 ml씩 2개 이상 도말하였다. 30 ∼35 ℃ 배양기에서 3일간 배양한 다음, 각 평판내의 집락수를 측정하여 합한 후, 사용한 평판수로 나누어 평판당 평균 집락수를 계산하였다.0.1 ml of the bacterial solution incubated in Nutrient broth and Tryptic soy broth for 24 hours and 10 ml of the disinfectant wash prepared in Example 1 were shaken and reacted for 1 minute. After 1 minute, 1 ml of the reaction solution was immediately added with 9 ml of neutralizing agent (4.26% sodium phosphate dibasic, 3% Tween, 0.5% sodium thiosulfate pentahydrate, 0.3% L-α-lecithin, and 0.1% L- Histidine). 1 ml of the mixture was taken and diluted 10-fold with peptone water. Each of the stock solution of the mixed solution and the diluted solution diluted 10-fold were prepared in advance and plated at least two by 0.1 ml in the solidified plate medium. After culturing for 3 days at 30-35 ° C. incubator, the number of colonies in each plate was measured and summed, and then divided by the number of used plates to calculate the average number of colonies per plate.
2. 진균 살균력 시험 2. Fungal Sterilization Test
효모 맥아 배지(Yeast malt broth)에서 48시간 배양한 균 액 0.1 ml과 실시예 1에서 제조한 소독 세척제 10 ml을 진탕 혼합하여 10분 동안 반응시켰다. 10분 후, 반응액 1 ml을 즉시 9 ml의 중화제(4.26% 소디움포스페이트 디베이직, 3% 트윈(Tween), 0.5% 소디움티오설페이트 펜타하이드레이트, 0.3% L-α-레시틴, 및 0.1% L-히스티딘)가 든 시험관에 취하였다. 혼합액 1 ml을 취하여 펩톤수로 10배 희석하였다. 혼합액의 원액과 10배 희석한 희석액 각각을 미리 제조하여 굳혀 둔 평판배지에 0.1 ml씩 2개이상 도말하였다. 20 ∼ 25 ℃ 배양기에서 7일간 배양한 다음, 각 평판내의 집락수를 측정하여 합한 후, 사용한 평판수로 나누어 평판당 평균 집락수를 계산하였다.0.1 ml of the bacterial solution incubated in yeast malt broth for 48 hours and 10 ml of the disinfectant cleaner prepared in Example 1 were shaken and reacted for 10 minutes. After 10 minutes, 1 ml of the reaction was immediately added to 9 ml of neutralizing agent (4.26% sodium phosphate dibasic, 3% Tween, 0.5% sodium thiosulfate pentahydrate, 0.3% L-α-lecithin, and 0.1% L- Histidine). 1 ml of the mixture was taken and diluted 10-fold with peptone water. Each stock and 10-fold dilutions of the mixed solution were prepared in advance and plated with two or more 0.1 ml plates of solidified plate medium. After culturing for 7 days at 20 to 25 ° C. incubator, the number of colonies in each plate was measured and summed, and then divided by the number of plates used to calculate the average number of colonies per plate.
상기 세균 및 진균에 대한 살균력 시험결과는 다음 표2와 같다.The bactericidal power test results for the bacteria and fungi are shown in Table 2 below.
상기 표2에서 확인할 수 있는 바와 같이, 본 발명의 소독 세척제는 세균 및 진균에 대하여 효과적인 살균력을 가지고 있음을 알 수 있다.As can be seen in Table 2, it can be seen that the disinfectant cleaner of the present invention has an effective bactericidal power against bacteria and fungi.
본 발명의 의료기기 소독 세척제에 의하면, 소독력의 감소없이 세척력을 효과적으로 증진시킬 수 있을 뿐 아니라, 기포 발생으로 인한 문제점 및 부식의 문제점을 최소화할 수 있다.According to the medical device disinfecting cleaning agent of the present invention, it is possible to effectively increase the cleaning power without reducing the disinfecting power, as well as to minimize the problems caused by bubbles and corrosion problems.
Claims (6)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0051154A KR100515928B1 (en) | 2002-08-28 | 2002-08-28 | A composition for disinfecting and washing medical instruments comprising a surfactant having alcohol groups at the both terminals and a process for the preparation thereof 1 |
PCT/KR2003/001742 WO2004020562A1 (en) | 2002-08-28 | 2003-08-28 | A composition for disinfecting or washing medical instruments and a process for the preparation thereof |
CNB038247496A CN1297644C (en) | 2002-08-28 | 2003-08-28 | A composition for disinfecting or washing medical instruments and a process for the preparation thereof |
AU2003253481A AU2003253481A1 (en) | 2002-08-28 | 2003-08-28 | A composition for disinfecting or washing medical instruments and a process for the preparation thereof |
JP2004532432A JP2005537356A (en) | 2002-08-28 | 2003-08-28 | Medical device disinfecting or cleaning composition and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0051154A KR100515928B1 (en) | 2002-08-28 | 2002-08-28 | A composition for disinfecting and washing medical instruments comprising a surfactant having alcohol groups at the both terminals and a process for the preparation thereof 1 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040019568A KR20040019568A (en) | 2004-03-06 |
KR100515928B1 true KR100515928B1 (en) | 2005-09-20 |
Family
ID=31973552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2002-0051154A KR100515928B1 (en) | 2002-08-28 | 2002-08-28 | A composition for disinfecting and washing medical instruments comprising a surfactant having alcohol groups at the both terminals and a process for the preparation thereof 1 |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP2005537356A (en) |
KR (1) | KR100515928B1 (en) |
CN (1) | CN1297644C (en) |
AU (1) | AU2003253481A1 (en) |
WO (1) | WO2004020562A1 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060285995A1 (en) * | 2005-06-15 | 2006-12-21 | 3M Innovative Properties Company | Compositions and methods of use |
EP1860176A1 (en) * | 2006-05-22 | 2007-11-28 | Akzo Nobel N.V. | Aqueous hydrogen peroxide-containing composition and its use for cleaning surfaces |
JP2008056870A (en) * | 2006-09-04 | 2008-03-13 | Miura Co Ltd | Cleaning fluid |
FR2932094B1 (en) * | 2008-06-05 | 2014-06-20 | Anios Lab Sarl | COMPOSITION FOR SIMULTANEOUS DISINFECTION AND DECONTAMINATION OF CONTAMINATED BODIES BY CONVENTIONAL (ATC) AND UNCONVENTIONAL TRANSMISSIBLE AGENTS (ATNC). |
FR2932093B1 (en) * | 2008-06-05 | 2012-07-20 | Anios Lab Sarl | COMPOSITION FOR SIMULTANEOUS DISINFECTION AND DECONTAMINATION OF CONTAMINATED BODIES BY CONVENTIONAL (ATC) AND UNCONVENTIONAL TRANSMISSIBLE AGENTS (ATNC). |
US11006629B2 (en) | 2008-11-20 | 2021-05-18 | Armis Biopharma, Inc. | Antimicrobial, disinfecting, and wound healing compositions and methods for producing and using the same |
US20110217204A1 (en) * | 2010-03-05 | 2011-09-08 | Franciskovich Phillip P | Sterilization composition |
US8691018B2 (en) | 2010-08-27 | 2014-04-08 | Ecolab Usa Inc. | High molecular weight polyacrylates for aluminum protection in warewash applications |
US8263540B2 (en) | 2010-08-27 | 2012-09-11 | Ecolab Usa Inc. | Detergent compositions with combinations of acrylic and maleic acid homopolymers and/or salts thereof for aluminum protection |
CN102258803B (en) * | 2011-07-20 | 2013-12-04 | 安立 | Long-acting medical skin sterilization cotton ball |
CN103849498A (en) * | 2012-11-29 | 2014-06-11 | 埃科莱布美国股份有限公司 | Cleaning additive and cleaning method adopting the cleaning additive |
US10869479B2 (en) | 2014-04-28 | 2020-12-22 | American Sterilizer Company | Wipe for killing spores |
US10463754B2 (en) | 2014-04-28 | 2019-11-05 | American Sterilizer Company | Process for decontaminating or sterilizing an article |
CN104798782B (en) * | 2015-04-16 | 2016-09-14 | 郭宝丽 | Oxirane disinfection liquid and preparation and using method |
US10183087B2 (en) | 2015-11-10 | 2019-01-22 | American Sterilizer Company | Cleaning and disinfecting composition |
US20220023475A1 (en) * | 2019-02-15 | 2022-01-27 | Whiteley Corporation Pty Ltd | Improved endoscope disinfectant |
WO2020252402A1 (en) * | 2019-06-14 | 2020-12-17 | Armis Biopharma, Inc. | Compositions for cleansing removable dental prosthetics |
KR102586840B1 (en) * | 2023-03-21 | 2023-10-11 | 김용철 | Semiconductor line robot cleaner composition |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970004585A (en) * | 1995-06-20 | 1997-01-29 | 김광호 | Remote control device of home appliance using wireless telephone in home automation system |
KR19990082255A (en) * | 1996-12-02 | 1999-11-25 | 가오가부시끼가이샤 | Surfactant composition |
KR20000049667A (en) * | 2000-04-21 | 2000-08-05 | 이진식 | A medical instrument cleaning solution using peracetic acid and the manufacturing method of the above solution |
JP2001072996A (en) * | 1999-09-02 | 2001-03-21 | Asahi Denka Kogyo Kk | Bactericidal detergent composition |
KR20010078279A (en) * | 2000-02-04 | 2001-08-20 | 고사이 아끼오 | Electronic parts cleaning solution |
KR20010111234A (en) * | 2000-06-09 | 2001-12-17 | 안용찬 | The aqueous aerosol cleaner composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2639233B1 (en) * | 1988-11-23 | 1994-05-06 | Air Liquide | HEMODIALYSIS HYGIENE AGENT |
AU661862B2 (en) * | 1991-07-15 | 1995-08-10 | Minntech Corporation | Stable, anticorrosive peracetic/peroxide sterilant |
GB9122048D0 (en) * | 1991-10-17 | 1991-11-27 | Interox Chemicals Ltd | Compositions and uses thereof |
JP3758417B2 (en) * | 1998-06-02 | 2006-03-22 | ニプロ株式会社 | Dialysis machine cleaning method |
-
2002
- 2002-08-28 KR KR10-2002-0051154A patent/KR100515928B1/en active IP Right Grant
-
2003
- 2003-08-28 CN CNB038247496A patent/CN1297644C/en not_active Expired - Fee Related
- 2003-08-28 WO PCT/KR2003/001742 patent/WO2004020562A1/en active Search and Examination
- 2003-08-28 JP JP2004532432A patent/JP2005537356A/en active Pending
- 2003-08-28 AU AU2003253481A patent/AU2003253481A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970004585A (en) * | 1995-06-20 | 1997-01-29 | 김광호 | Remote control device of home appliance using wireless telephone in home automation system |
KR19990082255A (en) * | 1996-12-02 | 1999-11-25 | 가오가부시끼가이샤 | Surfactant composition |
JP2001072996A (en) * | 1999-09-02 | 2001-03-21 | Asahi Denka Kogyo Kk | Bactericidal detergent composition |
KR20010078279A (en) * | 2000-02-04 | 2001-08-20 | 고사이 아끼오 | Electronic parts cleaning solution |
KR20000049667A (en) * | 2000-04-21 | 2000-08-05 | 이진식 | A medical instrument cleaning solution using peracetic acid and the manufacturing method of the above solution |
KR20010111234A (en) * | 2000-06-09 | 2001-12-17 | 안용찬 | The aqueous aerosol cleaner composition |
Also Published As
Publication number | Publication date |
---|---|
CN1297644C (en) | 2007-01-31 |
WO2004020562A1 (en) | 2004-03-11 |
AU2003253481A1 (en) | 2004-03-19 |
CN1694948A (en) | 2005-11-09 |
JP2005537356A (en) | 2005-12-08 |
KR20040019568A (en) | 2004-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100515928B1 (en) | A composition for disinfecting and washing medical instruments comprising a surfactant having alcohol groups at the both terminals and a process for the preparation thereof 1 | |
AP935A (en) | Quick acting chemical sterilant. | |
Nelson et al. | Transmission of tuberculosis by flexible fiberbronchoscopes | |
KR101494837B1 (en) | Sterilizing Composition | |
US6207201B1 (en) | Sodium hypochlorite based disinfectant and sterilizer for medical-surgical instruments | |
US9795132B2 (en) | Couplers for medium-chain fatty acids and disinfecting compositions | |
EP2236594B1 (en) | Method for removing biofilms | |
KR20010107920A (en) | Bactericidal/disinfectant peracetic acid composition | |
CN113645845B (en) | Improved endoscope disinfectant | |
JP2006206535A (en) | Washing disinfectant for medical equipment | |
EP1117294B1 (en) | Multi-part anti-microbial sterilization compositions and methods | |
KR100515929B1 (en) | A composition for disinfecting and washing medical instruments comprising a surfactant having alcohol groups at the both terminals and a process for the preparation thereof 2 | |
TWI681716B (en) | Liquid acetyl radicals generator composition | |
US20070286907A1 (en) | Germicide composition | |
EP0701400A1 (en) | Sodium hypochlorite based disinfectant and sterilizer for medical-surgical instruments | |
CN111226977A (en) | Environment-friendly sterilizing agent for medical instruments and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120628 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20130904 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20140829 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20150914 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20160912 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20170912 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20180912 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20190910 Year of fee payment: 15 |